PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny ...

Because of the lack of screening programmes and the fact that a significant proportion of HCC presents as symptomatic disease in individuals not known to have liver disease, most non-surgical ...

Recent advancements in liver imaging ... with gadoxetic acid-enhanced MRI has further increased the specificity and sensitivity in identifying HCC, even for nodules smaller than 1 cm.

The most common primary malignancy of the liver, hepatocellular carcinoma (HCC), is a heterogeneous tumor entity with high metastatic potential and complex pathophysiology. Increasing evidence ...

At an early stage, liver fibrosis is a dynamic and reversible process, however, from the cirrhotic stage, there is significant progression to hepatocellular carcinoma. Both liver-resident macrophages ...

Fluorescence navigation is a novel technique for accurately identifying hepatocellular carcinoma (HCC) lesions during hepatectomy, enabling real-time visualization. Indocyanine green-based ...

The gut microbiota promotes HCC development by the microbiota-liver axis in HCC animal models, but microbial characteristics in patients with HCC have not been reported. The concept of the gut ...

Objectives: To use baseline variables to predict one-year disease control for patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization ... subsequent contrast-enhanced ...

In conclusion, we compared quadruple-phase MDCT with state-of-the-art MRI for the diagnosis of focal and diffuse liver disease. Given the diagnostic superiority of MRI over CT, its lack of ...